Herbal remedy used to treat hepatitis C proves ineffective, Penn study finds
New findings show conflicting evidence on the benefits of using silymarin to treat chronic liver disease
2012-07-20
(Press-News.org) PHILADELPHIA - Silymarin, an extract of milk thistle commonly used to treat chronic liver disease by millions of people around the World, does not offer significant improvements for patients, according to a new study conducted by a nationwide group of researchers including faculty at the Perelman School of Medicine at the University of Pennsylvania. Milk thistle fruit extracts have been widely used by patients in treating liver disease based on previous evidence showing that it has anti-inflammatory, anti-oxidant, and potentially anti-viral properties. However, the new study is the first rigorous trial of its kind conducted to assess true efficacy in a group of hepatitis C patients who were previously unsuccessfully treated with interferon-based therapy – the standard anti-viral method used to treat the disease. Full results of the study are published in the July 18 issue of The Journal of the American Medical Association.
The Centers for Disease Control and Prevention (CDC) estimates that 3.2 million persons in the United States have chronic hepatitis C virus (HCV) infection. Of those, the study says 33 percent have reported current or past use of silymarin to treat the disease. The new study was designed to measure the potential benefit of increasing doses of silymarin in patients with chronic HCV. To determine efficacy, researchers monitored levels of serum alaninie aminotransferase (ALT) – the enzyme found in the blood stream that is most often tested to identify liver disease. Low levels of ALT are normally found in the blood, but are elevated when the liver is damaged or diseased. Secondary outcomes included quality-of-life measures.
"By all indications, silymarin is no more effective at treating hepatitis C related chronic liver disease, in those who failed standard therapy with interferon, than a placebo," said K. Rajender Reddy, MD, professor of Medicine and medical director of Liver Transplantation at Penn Medicine, and senior author of the study. "This is a landmark study as millions of people around the world are looking for supplements and other forms of alternative medicines to help reduce ALT levels every year."
The trial, which included 154 adult participants with chronic HCV, was conducted over the course of two years at four medical centers in the United States. Participants were randomly assigned to receive 420mg silymarin, 700mg silymarin or a matching placebo administered three times/week for 24 weeks, a standard duration of treatment. After 24 weeks, researchers found only two participants in each treatment group achieved lowered ALT levels. Neither the average decline in ALT activity nor quality-of-life measures at the end of treatment differed significantly across the treatment groups.
"These data show that even higher-than-normal doses of silymarin don't significantly reduce ALT levels for patients with HCV," said Reddy, noting that the doses used in the trial were three and five times higher than the customary dose. "At the end of the trial we saw no significant changes in physical or mental health assessments between the patients who received treatment, and those who did not. Quality-of-life measures were also largely unchanged."
###
The study was supported by grants from the National Institutes of Health (NIH) National Center for Complementary and Alternative Medicine (NCCAM) (UO1 AT003571, UO1 AT 003560, IO1 AT 003573, UO1 AT003566, and UO1 AT003574); with cofounding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); and with support from the NIH Clinical & Translational Sciences Awards Division of Research Resources (UUL1 RR024134, UL1 TR000083). The trial was conducted under an investigational New Drug Application from the US Food and Drug Administration.
END
ELSE PRESS RELEASES FROM THIS DATE:
2012-07-20
A new study from Lund University in Sweden has opened the way for new approaches to slowing the development of AIDS in HIV-1-infected patients. It is hoped that this could lead to better treatment methods and preventive measures to combat HIV and AIDS.
The findings have just been published in the distinguished scientific journal New England Journal of Medicine.
The most common type of the virus that causes AIDS – HIV-1 – is less aggressive when it infects a person already carrying the milder HIV-2. The study looked at how the disease developed in those who had been ...
2012-07-20
MANHATTAN, KAN. -- A ratings system developed by a group of Kansas State University researchers could keep bridges safer and help prevent catastrophic collapses.
Hayder Rasheed, associate professor of civil engineering, and Yacoub Najjar, professor of civil engineering, are collaborating to better detect and measure damage in concrete bridges. Ahmed Al-Rahmani, doctoral student in civil engineering, United Arab Emirates, has also been involved in the project.
The researchers have created a bridge health index, which is a rating system that more accurately describes ...
2012-07-20
Big data needs big power. The server farms that undergird the Internet run on a vast tide of electricity. Even companies that have invested in upgrades to minimize their eco-footprint use tremendous amounts: The New York Times estimates that Google, for example, uses enough electricity in its data centers to power about 200,000 homes.
Now, a team of Princeton University engineers has a solution that could radically cut that power use. Through a new software technique, researchers from the School of Engineering and Applied Science have opened the door for companies to ...
2012-07-20
NEW YORK (July 19, 2012)— A dramatic photo of a male leopard dragging a massive gaur (or Indian bison) calf in Karnataka's Bandipur Tiger Reserve turned out to be the same animal photographed by a WCS camera trap nearly eight years ago.
The photo, taken by Indian photographer Vinay S. Kumar, was initially submitted to Conservation India, a not-for-profit portal to enable conservation action. Intrigued by the picture, CI's editors sent it to researchers at Wildlife Conservation Society's India Program who have been running a tiger-monitoring program for over two decades ...
2012-07-20
Tired? Scientists have discovered another possible benefit of a night of restful and uninterrupted sleep. According to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health fragmented or interrupted sleep could predict future placement in a nursing home or assisted living facility. The study is featured in the July 2012 issue of the Journal of the American Geriatrics Society and outlines the association between objectively measured sleep and subsequent institutionalization among older women.
"Sleep disturbances are common in older people," ...
2012-07-20
(Edmonton, AB) New research from the University of Alberta's School of Public Health has demonstrated that community-based resources in rural Uganda can successfully provide HIV treatments to patients, where economic and geographical barriers would typically prevent access to care.
Working with the Kabarole District Health Department and colleagues at Makerere University in Kampala, Uganda, the researchers implemented a new model by which volunteers were trained to provide basic care to HIV patients in Rwimi sub-county.
When comparing the viral loads of 185 patients ...
2012-07-20
UT Dallas researchers recently demonstrated how nerve stimulation paired with specific experiences, such as movements or sounds, can reorganize the brain. This technology could lead to new treatments for stroke, tinnitus, autism and other disorders.
In a related paper, The University of Texas at Dallas neuroscientists showed that they could alter the speed at which the brain works in laboratory animals by pairing stimulation of the vagus nerve with fast or slow sounds.
A team led by Dr. Robert Rennaker and Dr. Michael Kilgard looked at whether repeatedly pairing vagus ...
2012-07-20
Philadelphia, PA, July 19, 2012 – Outpatient heart failure (HF) clinics that provide patient education on ways to manage heart failure and risk factors, prescribe home-based exercises, and monitor therapy compliance have been shown to reduce morbidity, mortality, and health care costs. A new study published in the current issue of the Canadian Journal of Cardiology finds that despite guidelines that encourage physicians to recommend heart failure clinics, very few patients recently hospitalized with HF receive referrals or use one.
"Given the demonstrated benefits of ...
2012-07-20
A majority of previous epidemiologic studies have shown that moderate drinking is associated with a lower risk of kidney cancer, which may affect about 1% of the general population. In published prospective cohort studies, the risk for such cancer among moderate drinkers is usually about 25% less than the risk seen among non-drinkers.
This well-done meta-analysis supports these findings: for the more-reliable prospective cohort studies (rather than case-control studies) the current study finds a 29% lower risk for subjects in the highest category of alcohol consumption ...
2012-07-20
Philadelphia, PA, July 19, 2012 – The recent Supreme Court decision on the Patient Protection and Affordable Care Act has cleared the way for national requirements about posting nutritional information at chain restaurants. Listing calories, fat content, and sodium levels of menu items at the point of purchase has been promoted as a way to address the obesity epidemic. Increased awareness may lead to healthier consumer choices, and may encourage restaurants to adapt their menus to meet demand. A new study has evaluated the real-life impact of menu labeling in King County, ...
LAST 30 PRESS RELEASES:
[Press-News.org] Herbal remedy used to treat hepatitis C proves ineffective, Penn study finds
New findings show conflicting evidence on the benefits of using silymarin to treat chronic liver disease
